Back to Top
New Products
-
-
-
-
Telisotuzumab Vedotin Biosimilar - Research Grade$700.00 - $3,024.00
-
Depatuxizumab-Mafodotin Biosimilar - Research Grade$700.00 - $3,024.00
-
-
-
Datopotamab Deruxtecan Biosimilar - Research Grade$700.00 - $3,024.00
-
-
Patritumab Deruxtecan Biosimilar - Research Grade$700.00 - $3,024.00
-
-
Zilovertamab Vedotin Biosimilar - Research Grade$700.00 - $3,024.00